1. Home
  2. NRC vs PRTC Comparison

NRC vs PRTC Comparison

Compare NRC & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRC
  • PRTC
  • Stock Information
  • Founded
  • NRC 1981
  • PRTC 2015
  • Country
  • NRC United States
  • PRTC United States
  • Employees
  • NRC N/A
  • PRTC N/A
  • Industry
  • NRC Biotechnology: Commercial Physical & Biological Resarch
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRC Health Care
  • PRTC Health Care
  • Exchange
  • NRC Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • NRC 394.2M
  • PRTC 457.3M
  • IPO Year
  • NRC N/A
  • PRTC N/A
  • Fundamental
  • Price
  • NRC $15.61
  • PRTC $18.47
  • Analyst Decision
  • NRC
  • PRTC Buy
  • Analyst Count
  • NRC 0
  • PRTC 1
  • Target Price
  • NRC N/A
  • PRTC $45.00
  • AVG Volume (30 Days)
  • NRC 78.5K
  • PRTC 1.8K
  • Earning Date
  • NRC 01-27-2025
  • PRTC 08-28-2024
  • Dividend Yield
  • NRC 3.08%
  • PRTC N/A
  • EPS Growth
  • NRC N/A
  • PRTC N/A
  • EPS
  • NRC 1.04
  • PRTC N/A
  • Revenue
  • NRC $143,060,000.00
  • PRTC $468,000.00
  • Revenue This Year
  • NRC N/A
  • PRTC N/A
  • Revenue Next Year
  • NRC N/A
  • PRTC $160.00
  • P/E Ratio
  • NRC $15.01
  • PRTC N/A
  • Revenue Growth
  • NRC N/A
  • PRTC N/A
  • 52 Week Low
  • NRC $15.59
  • PRTC $17.00
  • 52 Week High
  • NRC $42.00
  • PRTC $34.00
  • Technical
  • Relative Strength Index (RSI)
  • NRC 35.77
  • PRTC 46.10
  • Support Level
  • NRC $16.92
  • PRTC $18.35
  • Resistance Level
  • NRC $18.41
  • PRTC $18.89
  • Average True Range (ATR)
  • NRC 0.68
  • PRTC 0.43
  • MACD
  • NRC -0.07
  • PRTC 0.00
  • Stochastic Oscillator
  • NRC 0.73
  • PRTC 26.62

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

Share on Social Networks: